Longevity Acquisition Corporation Right
LOACR
LOACR was delisted on the 19th of March, 2021.
15 hedge funds and large institutions have $589K invested in Longevity Acquisition Corporation Right in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
7% more capital invested
Capital invested by funds: $548K → $589K (+$41K)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$325 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$25K |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$14.2K |
LOACR Hedge Fund Activity: Q3 2020 in Review
15 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Right (LOACR) for Q3 2020, worth a combined $589K — up 7.5% from $548K a quarter earlier.
Fund positioning in LOACR was balanced in Q3 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $325. The largest seller was AQR Arbitrage, exiting entirely with an estimated $25K sold.
- 15 institutional investors held Longevity Acquisition Corporation Right (LOACR) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $589K of Longevity Acquisition Corporation Right stock for Q3 2020, up 7.5% quarter-over-quarter.
- 1 fund opened new Longevity Acquisition Corporation Right positions in Q3 2020 and 1 closed out, a net change of 0 holders.
- The largest Longevity Acquisition Corporation Right buyer in Q3 2020 was UBS Group, an estimated $325 added.
- The largest Longevity Acquisition Corporation Right seller in Q3 2020 was AQR Arbitrage, an estimated $25K sold.
Based on aggregated 13F filings for Q3 2020.